Fig. 1From: Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancerOverall survival (a) and progression-free survival (c) for all patients and stratified by synchronous vs. metachronous occurrence of oligometastic disease (b, d). The vertical markings indicate censored patients. The x-axis is capped at 121 months follow-up in all graphs, as in all groups two or less patients underwent a follow-up exceeding the presented intervalBack to article page